SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-22-004615
Filing Date
2022-03-29
Accepted
2022-03-29 16:19:02
Documents
87
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K nbrv-20211231x10k.htm   iXBRL 10-K 3901592
2 EX-10.57 nbrv-20211231xex10d57.htm EX-10.57 51263
3 EX-10.58 nbrv-20211231xex10d58.htm EX-10.58 43773
4 EX-21.1 nbrv-20211231xex21d1.htm EX-21.1 6326
5 EX-23.1 nbrv-20211231xex23d1.htm EX-23.1 2737
6 EX-31.1 nbrv-20211231xex31d1.htm EX-31.1 11354
7 EX-31.2 nbrv-20211231xex31d2.htm EX-31.2 11198
8 EX-32.1 nbrv-20211231xex32d1.htm EX-32.1 5782
9 EX-32.2 nbrv-20211231xex32d2.htm EX-32.2 6581
10 GRAPHIC nbrv-20211231x10k001.jpg GRAPHIC 18236
  Complete submission text file 0001558370-22-004615.txt   12237742

Data Files

Seq Description Document Type Size
11 EX-101.SCH nbrv-20211231.xsd EX-101.SCH 77815
12 EX-101.CAL nbrv-20211231_cal.xml EX-101.CAL 75777
13 EX-101.DEF nbrv-20211231_def.xml EX-101.DEF 306026
14 EX-101.LAB nbrv-20211231_lab.xml EX-101.LAB 680441
15 EX-101.PRE nbrv-20211231_pre.xml EX-101.PRE 503883
81 EXTRACTED XBRL INSTANCE DOCUMENT nbrv-20211231x10k_htm.xml XML 1816761
Mailing Address 414 COMMERCE DRIVE STE 120 FORT WASHINGTON PA 19034
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 D01 H104 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37558 | Film No.: 22781072
SIC: 2834 Pharmaceutical Preparations